| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.AJKD.2007.02.270 |
| P698 | PubMed publication ID | 17472840 |
| P2093 | author name string | Elena N Levtchenko | |
| Jack F M Wetzels | |||
| Henriette A C Kyrieleis | |||
| P433 | issue | 5 | |
| P921 | main subject | nephrotic syndrome | Q504790 |
| P304 | page(s) | 592-597 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome | |
| P478 | volume | 49 |
| Q87402193 | Chapter 3: Steroid-sensitive nephrotic syndrome in children |
| Q83602331 | Clinical course and outcome of children with steroid-sensitive nephrotic syndrome |
| Q53625850 | Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. |
| Q83587128 | Cyclophosphamide in steroid-dependent nephrotic syndrome |
| Q84921847 | Dosing of glucocorticosteroids in nephrotic syndrome |
| Q40220069 | Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai |
| Q38246219 | Fertility preservation in patients receiving cyclophosphamide therapy for renal disease |
| Q90530006 | Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study |
| Q39881156 | Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience |
| Q83602335 | Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome |
| Q34659232 | Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children |
| Q35712990 | Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience |
| Q85669293 | Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial |
| Q38854254 | Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment |
| Q37828086 | New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome |
| Q91845237 | Prediction of Short- and Long-Term Outcomes in Childhood Nephrotic Syndrome |
| Q57945954 | References |
| Q33762358 | Revised guidelines for management of steroid-sensitive nephrotic syndrome |
| Q86810262 | Rituximab for patients with nephrotic syndrome |
| Q85906649 | Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease |
| Q43202423 | Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine |
| Q37902094 | The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease |
| Q36294318 | Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children |
| Q91845232 | Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome |
Search more.